An open chat with… Sandro Sonnino DOI Creative Commons
Ioannis Tsagakis, Sandro Sonnino

FEBS Open Bio, Journal Year: 2023, Volume and Issue: 13(9), P. 1544 - 1547

Published: Aug. 17, 2023

Sandro Sonnino is one of the founding members Editorial Board FEBS Open Bio , having joined in 2011. He also a member Letters and Editor‐in‐Chief Glycoconjugate Journal . full professor biochemistry School Medicine at University Milan, where he was formerly coordinator Interdisciplinary Laboratory Advanced Technology (LITA) Director Department Medical Chemistry, Biochemistry, Biotechnology. His research focused on metabolism biochemical properties gangliosides glycosphingolipids, their role cell signaling nervous system. guest editor this special “In Limelight” issue glycosphingolipids disease, which features multiple Reviews an original article related to field. In interview, discusses ongoing importance his personal career journey.

Language: Английский

Don’t Be Surprised When These Surprise You: Some Infrequently Studied Sphingoid Bases, Metabolites, and Factors That Should Be Kept in Mind During Sphingolipidomic Studies DOI Open Access
Alfred H. Merrill

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(2), P. 650 - 650

Published: Jan. 14, 2025

Sphingolipidomic mass spectrometry has provided valuable information-and surprises-about sphingolipid structures, metabolism, and functions in normal biological processes disease. Nonetheless, many noteworthy compounds are not routinely determined, such as the following: most of sphingoid bases that mammals biosynthesize de novo other than sphingosine (and sometimes sphinganine) or acquire from exogenous sources; infrequently considered metabolites bases, N-(methyl)n-derivatives; "ceramides" common N-acylsphingosines; complex sphingolipids sphingomyelins simple glycosphingolipids, including glucosyl- galactosylceramides, which usually reported "monohexosylceramides". These subspecies discussed, well some circumstances when they likely to be seen (or present missed) due experimental conditions can influence uptake diet microbiome, artifacts produced during extraction analysis. If these factors kept mind design interpretation lipidomic studies, investigators surprised by how often appear thereby advance knowledge about them.

Language: Английский

Citations

2

Serum antibody screening using glycan arrays DOI
Samantha Marglous, Claire Brown, Vered Padler‐Karavani

et al.

Chemical Society Reviews, Journal Year: 2024, Volume and Issue: 53(5), P. 2603 - 2642

Published: Jan. 1, 2024

Humans and other animals produce a diverse collection of antibodies, many which bind to carbohydrate chains, referred as glycans. These anti-glycan antibodies are critical part our immune systems' defenses. Whether induced by vaccination or natural exposure pathogen, can provide protection against infections cancers. Alternatively, when an response goes awry, that recognize self-glycans mediate autoimmune diseases. In any case, serum rich source information about patient's overall health, history, disease status. Glycan microarrays high-throughput platform rapidly interrogate identify new biomarkers for variety conditions. addition, glycan enable detailed analysis the system's vaccines treatments. Herein we review applications microarray technology antibody profiling.

Language: Английский

Citations

9

The Bioactive Sphingolipid Playbook. A Primer for the Uninitiated as well as Sphingolipidologists DOI Creative Commons
Yusuf A. Hannun, Alfred H. Merrill,

Chiara Luberto

et al.

Journal of Lipid Research, Journal Year: 2025, Volume and Issue: unknown, P. 100813 - 100813

Published: April 1, 2025

Language: Английский

Citations

0

Glycolipidomics of Liver Flukes and Host Tissues during Fascioliasis: Insights from Mass Spectrometry Imaging DOI Creative Commons
David Luh, Parviz Ghezellou, Sven Heiles

et al.

ACS Infectious Diseases, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 7, 2024

Fascioliasis, a zoonotic disease caused by liver flukes of the genus

Language: Английский

Citations

0

An open chat with… Sandro Sonnino DOI Creative Commons
Ioannis Tsagakis, Sandro Sonnino

FEBS Open Bio, Journal Year: 2023, Volume and Issue: 13(9), P. 1544 - 1547

Published: Aug. 17, 2023

Sandro Sonnino is one of the founding members Editorial Board FEBS Open Bio , having joined in 2011. He also a member Letters and Editor‐in‐Chief Glycoconjugate Journal . full professor biochemistry School Medicine at University Milan, where he was formerly coordinator Interdisciplinary Laboratory Advanced Technology (LITA) Director Department Medical Chemistry, Biochemistry, Biotechnology. His research focused on metabolism biochemical properties gangliosides glycosphingolipids, their role cell signaling nervous system. guest editor this special “In Limelight” issue glycosphingolipids disease, which features multiple Reviews an original article related to field. In interview, discusses ongoing importance his personal career journey.

Language: Английский

Citations

1